Invivyd IVVD
NASDAQ IVVD
$0.60 +0.02 (+4.01%)
As of: Nov 11, 2026 · 3:59 PM EST

Invivyd (IVVD) Preferred Stock Liabilities (2020 - 2021)

Updated

Invivyd's Preferred Stock Liabilities was $504.71 million in Q2 2021.

Analysis

Invivyd (IVVD) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends

At the end of FY2020, Preferred Stock Liabilities at Invivyd came in at $169.55 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Invivyd 168.01 Mn -487.88 Mn 13.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 504.71 Mn
Dec 31, 2020 169.55 Mn
API Access

Invivyd Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=IVVD&period=max&api_key=YOUR_API_KEY